NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

While an ever increasing income from the UK "Specials" program is insignificant in the bigger long range picture that includes the MAA application, Regulatory approval etc., it could be quite significant in the short run (soon) because it signals that NWBO will be increasingly financially independent and can survive without outside help (toxic loans) until the good news finally arrives.

It can also suggest to both shorts and longs that a reduced share price will have little impact on the ever increasing revenues and hence the pre approval activities and survival of the company.